Cathay Chemical Works Inc

Cathay Chemical Works Inc maintains a strong liquidity position, with a current ratio of 7.87 and cash and equivalents of 23,000,000 TWD. The company's price-to-book ratio of 1.87 and price-to-tangible-book ratio of 1.87 suggest a moderate valuation relative to its book value. Despite a negative operating income of -79,244,000 TWD, the company reported a net income of 583,839,000 TWD, indicating strong non-operating income or gains. The company's profitability is highlighted by a return on equity of 15.33% and a return on assets of 14.69%, both exceeding the typical thresholds for the Commodity Chemicals industry. However, the negative operating income suggests operational challenges that may affect long-term sustainability. Cathay Chemical Works Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's revenue of 460,042,000 TWD is derived from its core chemical manufacturing activities. The lack of segment or geographic diversification increases exposure to sector-specific risks. The company's growth trajectory is mixed. While the latest reported revenue of 460,042,000 TWD is lower than the analyst estimate of 671,611,000 TWD, the net income of 583,839,000 TWD indicates strong profitability. The free cash flow of -550,470,000 TWD suggests significant capital expenditures or other outflows, which may impact future growth. Risk factors for Cathay Chemical Works Inc are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's low debt-to-equity ratio of 0.0 and minimal long-term debt of 811,000 TWD indicate a conservative capital structure. However, the negative operating income and high free cash flow outflows may signal underlying operational or strategic challenges. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's strong net income and liquidity position suggest it is well-positioned to navigate short-term challenges. However, the discrepancy between reported revenue and analyst estimates warrants further investigation.